An Untargeted Metabolomics Approach to Characterize Short-Term and Long-Term Metabolic Changes after Bariatric Surgery.
Bariatric surgery is currently one of the most effective treatments for obesity and leads to significant weight reduction, improved cardiovascular risk factors and overall survival in treated patients. To date, most studies focused on short-term effects of bariatric surgery on the metabolic profile...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5008721?pdf=render |
| _version_ | 1818951554876571648 |
|---|---|
| author | Sophie H Narath Selma I Mautner Eva Svehlikova Bernd Schultes Thomas R Pieber Frank M Sinner Edgar Gander Gunnar Libiseller Michael G Schimek Harald Sourij Christoph Magnes |
| author_facet | Sophie H Narath Selma I Mautner Eva Svehlikova Bernd Schultes Thomas R Pieber Frank M Sinner Edgar Gander Gunnar Libiseller Michael G Schimek Harald Sourij Christoph Magnes |
| author_sort | Sophie H Narath |
| collection | DOAJ |
| description | Bariatric surgery is currently one of the most effective treatments for obesity and leads to significant weight reduction, improved cardiovascular risk factors and overall survival in treated patients. To date, most studies focused on short-term effects of bariatric surgery on the metabolic profile and found high variation in the individual responses to surgery. The aim of this study was to identify relevant metabolic changes not only shortly after bariatric surgery (Roux-en-Y gastric bypass) but also up to one year after the intervention by using untargeted metabolomics. 132 serum samples taken from 44 patients before surgery, after hospital discharge (1-3 weeks after surgery) and at a 1-year follow-up during a prospective study (NCT01271062) performed at two study centers (Austria and Switzerland). The samples included 24 patients with type 2 diabetes at baseline, thereof 9 with diabetes remission after one year. The samples were analyzed by using liquid chromatography coupled to high resolution mass spectrometry (LC-HRMS, HILIC-QExactive). Raw data was processed with XCMS and drift-corrected through quantile regression based on quality controls. 177 relevant metabolic features were selected through Random Forests and univariate testing and 36 metabolites were identified. Identified metabolites included trimethylamine-N-oxide, alanine, phenylalanine and indoxyl-sulfate which are known markers for cardiovascular risk. In addition we found a significant decrease in alanine after one year in the group of patients with diabetes remission relative to non-remission. Our analysis highlights the importance of assessing multiple points in time in subjects undergoing bariatric surgery to enable the identification of biomarkers for treatment response, cardiovascular benefit and diabetes remission. Key-findings include different trend pattern over time for various metabolites and demonstrated that short term changes should not necessarily be used to identify important long term effects of bariatric surgery. |
| first_indexed | 2024-12-20T09:36:20Z |
| format | Article |
| id | doaj.art-a86c739739b54c31b1bd0d1d9abd40b1 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-20T09:36:20Z |
| publishDate | 2016-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-a86c739739b54c31b1bd0d1d9abd40b12022-12-21T19:44:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01119e016142510.1371/journal.pone.0161425An Untargeted Metabolomics Approach to Characterize Short-Term and Long-Term Metabolic Changes after Bariatric Surgery.Sophie H NarathSelma I MautnerEva SvehlikovaBernd SchultesThomas R PieberFrank M SinnerEdgar GanderGunnar LibisellerMichael G SchimekHarald SourijChristoph MagnesBariatric surgery is currently one of the most effective treatments for obesity and leads to significant weight reduction, improved cardiovascular risk factors and overall survival in treated patients. To date, most studies focused on short-term effects of bariatric surgery on the metabolic profile and found high variation in the individual responses to surgery. The aim of this study was to identify relevant metabolic changes not only shortly after bariatric surgery (Roux-en-Y gastric bypass) but also up to one year after the intervention by using untargeted metabolomics. 132 serum samples taken from 44 patients before surgery, after hospital discharge (1-3 weeks after surgery) and at a 1-year follow-up during a prospective study (NCT01271062) performed at two study centers (Austria and Switzerland). The samples included 24 patients with type 2 diabetes at baseline, thereof 9 with diabetes remission after one year. The samples were analyzed by using liquid chromatography coupled to high resolution mass spectrometry (LC-HRMS, HILIC-QExactive). Raw data was processed with XCMS and drift-corrected through quantile regression based on quality controls. 177 relevant metabolic features were selected through Random Forests and univariate testing and 36 metabolites were identified. Identified metabolites included trimethylamine-N-oxide, alanine, phenylalanine and indoxyl-sulfate which are known markers for cardiovascular risk. In addition we found a significant decrease in alanine after one year in the group of patients with diabetes remission relative to non-remission. Our analysis highlights the importance of assessing multiple points in time in subjects undergoing bariatric surgery to enable the identification of biomarkers for treatment response, cardiovascular benefit and diabetes remission. Key-findings include different trend pattern over time for various metabolites and demonstrated that short term changes should not necessarily be used to identify important long term effects of bariatric surgery.http://europepmc.org/articles/PMC5008721?pdf=render |
| spellingShingle | Sophie H Narath Selma I Mautner Eva Svehlikova Bernd Schultes Thomas R Pieber Frank M Sinner Edgar Gander Gunnar Libiseller Michael G Schimek Harald Sourij Christoph Magnes An Untargeted Metabolomics Approach to Characterize Short-Term and Long-Term Metabolic Changes after Bariatric Surgery. PLoS ONE |
| title | An Untargeted Metabolomics Approach to Characterize Short-Term and Long-Term Metabolic Changes after Bariatric Surgery. |
| title_full | An Untargeted Metabolomics Approach to Characterize Short-Term and Long-Term Metabolic Changes after Bariatric Surgery. |
| title_fullStr | An Untargeted Metabolomics Approach to Characterize Short-Term and Long-Term Metabolic Changes after Bariatric Surgery. |
| title_full_unstemmed | An Untargeted Metabolomics Approach to Characterize Short-Term and Long-Term Metabolic Changes after Bariatric Surgery. |
| title_short | An Untargeted Metabolomics Approach to Characterize Short-Term and Long-Term Metabolic Changes after Bariatric Surgery. |
| title_sort | untargeted metabolomics approach to characterize short term and long term metabolic changes after bariatric surgery |
| url | http://europepmc.org/articles/PMC5008721?pdf=render |
| work_keys_str_mv | AT sophiehnarath anuntargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT selmaimautner anuntargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT evasvehlikova anuntargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT berndschultes anuntargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT thomasrpieber anuntargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT frankmsinner anuntargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT edgargander anuntargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT gunnarlibiseller anuntargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT michaelgschimek anuntargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT haraldsourij anuntargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT christophmagnes anuntargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT sophiehnarath untargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT selmaimautner untargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT evasvehlikova untargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT berndschultes untargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT thomasrpieber untargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT frankmsinner untargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT edgargander untargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT gunnarlibiseller untargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT michaelgschimek untargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT haraldsourij untargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery AT christophmagnes untargetedmetabolomicsapproachtocharacterizeshorttermandlongtermmetabolicchangesafterbariatricsurgery |